Alnylam Pharmaceuticals is dedicated to advancing the field of RNA interference to create transformative medicines for patients with genetic diseases. The company focuses on its proprietary technologies to develop innovative therapeutics. The commitment to scientific advancement is reflected in its collaborative environment and emphasis on employee well-being.